Our Studies

• INA-PROACTIVE Study

  To collect standardized baseline and longitudinal data describing the course of HIV disease in antiretroviral-naive and treatment-experienced individuals to inform policy.

  TIMETABLE DETAILS

• PEER-Peppes Study

  Implementing a Combination of Clinical Parameters (Rapid Diagnostic Tests, Biomarkers and Standard of Care Procedures) for the Etiology Diagnosis of Pneumonia in Paediatric Patients to Improve Clinical Management in Indonesia

  TIMETABLE DETAILS

• ORCHID Study

  To identify COVID-19 and other respiratory infectious disease cases from hospitalized suspected COVID-19 patients.

  TIMETABLE DETAILS

• D2EFT Study

  to compare the virological efficacy of the three regimens in the intention to treat (ITT) population. Virological efficacy is defined as the proportion of participants with plasma HIV RNA (pVL) <50 copies/mL at 48 weeks.

  TIMETABLE DETAILS

• ICOS Study

  Among participants testing positive for SARS-CoV-2: Estimate the rate of hospitalization or death during the 28 day follow-up period. Identify risk factors for hospitalization or death.

  TIMETABLE DETAILS

• ITAC Study

  The primary endpoint of this trial in hospitalized patients is an ordinal outcome based on the patient’s clinical status on Day 7. It includes seven mutually exclusive categories capturing the range of organ dysfunction that may be associated with the progression of COVID-19, such as respiratory dysfunction and coagulation-related complications.

  TIMETABLE DETAILS

• AFIRE Study

  

  To identify the etiology of acute febrile illness cases and evaluate clinical manifestations and outcomes.

  TIMETABLE DETAILS

• Sepsis Study

  To determine the causes of community-acquired sepsis and severe sepsis in adults and pediatrics across Southeast Asia.

  TIMETABLE DETAILS

• TRIPOD Study

  To estimate the proportion of MDR TB amongst treatment naïve new treatment naïve and previously treated cases.

  TIMETABLE DETAILS